136 related articles for article (PubMed ID: 10724793)
1. The effect of generic competition on prescription to over-the-counter switching.
Hollenbeak CS
Pharmacoeconomics; 1999 Dec; 16(6):661-8. PubMed ID: 10724793
[TBL] [Abstract][Full Text] [Related]
2. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
Shih YC; Prasad M; Luce BR
Clin Ther; 2002 Apr; 24(4):701-16. PubMed ID: 12017413
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
Kohli E; Buller A
South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
[TBL] [Abstract][Full Text] [Related]
4. Improving the PPI sample for prescription pharmaceuticals.
Kelly GG
Mon Labor Rev; 1997 Oct; 120(10):10-7. PubMed ID: 10176326
[No Abstract] [Full Text] [Related]
5. The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms.
Zhang W; Guh D; Sun H; Marra CA; Lynd LD; Anis AH
Med Care; 2016 Sep; 54(9):884-90. PubMed ID: 27213540
[TBL] [Abstract][Full Text] [Related]
6. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
Levy MS
Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
[TBL] [Abstract][Full Text] [Related]
7. The importance of being first: evidence from Canadian generic pharmaceuticals.
Hollis A
Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
[TBL] [Abstract][Full Text] [Related]
8. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
9. Switching omeprazole in Sweden and the United States.
Cohen J
Am J Ther; 2003; 10(5):370-6. PubMed ID: 12975722
[TBL] [Abstract][Full Text] [Related]
10. An Administrative Meter Maid: Using Inter Partes Review and Post-Grant Review to Curb Exclusivity Parking via the "Failure to Market" Provision of the Hatch-Waxman Act.
Apel BT
Mich Law Rev; 2015; 114(1):107-36. PubMed ID: 26394458
[TBL] [Abstract][Full Text] [Related]
11. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
Kraushaar KJ
Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581
[No Abstract] [Full Text] [Related]
12. When is a market not a market?
MacLeod SM
CMAJ; 1993 Jan; 148(1):23-5. PubMed ID: 8439886
[No Abstract] [Full Text] [Related]
13. The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.
Carlsten A; Wennberg M; Bergendal L
J Clin Pharm Ther; 1996 Dec; 21(6):423-30. PubMed ID: 9201570
[TBL] [Abstract][Full Text] [Related]
14. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
15. [Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors].
Mahlich JC; Stadler I
Gesundheitswesen; 2012 Jan; 74(1):23-8. PubMed ID: 21154203
[TBL] [Abstract][Full Text] [Related]
16. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
17. The "prescription-to-OTC switch" movement. Its effects on antifungal vaginitis preparations.
Lipsky MS; Waters T
Arch Fam Med; 1999; 8(4):297-300. PubMed ID: 10418534
[TBL] [Abstract][Full Text] [Related]
18. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
19. Impacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance.
Zhao M; Wu J
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):311-320. PubMed ID: 27762144
[TBL] [Abstract][Full Text] [Related]
20. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
Kalish SC; Bohn RL; Avorn J
Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]